1. Share Prices

  2. E-Therapeutics PLC (ETX)

9.18p+0.33 (+3.67%)24 Apr 2024, 16:21
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo
Jump to:

E-Therapeutics PLC Fundamentals

Company NameE-Therapeutics PLCLast Updated2024-04-24
IndustryBiotechnologySectorHealthcare
Shares in Issue584.335 mMarket Cap£53.61 m
PE Ratio0.00Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-£0.02EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0.0031Debt Equity Ratio0
Asset Equity Ratio1.0463Cash Equity Ratio0.9024
Quick Ratio19.7077Current Ratio22.20
Price To Book Value1.8783ROCE0

E-Therapeutics PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

E-Therapeutics PLC Company Financials

Assets202320222021
Tangible Assets£400,000.00£805,000.00£79,000.00
Intangible Assets£239,000.00£102,000.00£83,000.00
Investments000
Total Fixed Assets£639,000.00£907,000.00£162,000.00
Stocks000
Debtors£259,000.00£236,000.00£57,000.00
Cash & Equivalents£31.69 m£26.40 m£13.03 m
Other Assets000
Total Assets£34.64 m£29.52 m£14.31 m
Liabilities202320222021
Creditors within 1 year£1.60 m£1.49 m£427,000.00
Creditors after 1 year0£295,000.000
Other Liabilities000
Total Liabilities£1.60 m£1.79 m£427,000.00
Net assets£33.04 m£27.73 m£13.88 m
Equity202320222021
Called up share capital£582,000.00£515,000.00£421,000.00
Share Premium£112.61 m£99.24 m£77.67 m
Profit / Loss-£9.77 m-£9.52 m-£4.47 m
Other Equity£33.04 m£27.73 m£13.88 m
Preference & Minorities000
Total Capital Employed£33.04 m£27.73 m£13.63 m
Ratios202320222021
Debt Ratio0£0.010
Debt-to-Equity0£0.010
Assets / Equity1.04631.04631.0463
Cash / Equity0.90240.90240.9024
EPS-£0.02-£0.02-£0.01
Cash Flow202320222021
Cash from operating activities-£8.01 m-£7.80 m-£3.36 m
Cashflow before financing£5.04 m£14.53 m£9.24 m
Increase in Cash£20.34 m£4.59 m£4.17 m
Income202320222021
Turnover£475,000.00£477,000.00£317,000.00
Cost of sales000
Gross Profit£475,000.00£477,000.00£317,000.00
Operating Profit-£10.24 m-£9.57 m-£4.49 m
Pre-Tax profit-£9.77 m-£9.52 m-£4.47 m

E-Therapeutics PLC Company Background

SectorHealthcare
Activitiese-Therapeutics PLC is a drug discovery company. Its ambition is to transform the drug discovery process, leveraging its computational network biology platform (drug discovery) to find novel targets to address mechanisms underpinning complex disease. l company activities are carried out in the UK.
Latest Interim Date26 Oct 2023
Latest Fiscal Year End Date4 May 2023

E-Therapeutics PLC Directors

AppointedNamePosition
2020-02-11Mr. Iain Gladstone RossNon-Executive Director,Chairman
2020-02-11Ms. Christine Helen SodenNon-Executive Director
2011-08-09Mr. Johnny Mark CordinerExecutive Director,Finance and Commercial Director
2024-01-09Professor Trevor Mervyn Jones CBENon-Executive Director,Chairman
2023-05-01Mr. Michael Anthony BrethertonNon-Executive Director
2015-05-12Professor Oliver Francis Wintour JamesNon-Executive Director,Chairman
2017-05-08Professor Malcolm Philip YoungExecutive Director,Chief Executive Officer
2011-08-09Dr. Royston Frederick DruckerExecutive Director,Chief Medical Officer
2018-04-04Mr. Bradley Richard HoyNon-Executive Director
2018-04-04Mr. Sean Torquil Nicolson Executive Director,Company Secretary
2018-04-04Mr. Stephen Raymond SelfExecutive Director,Development Director
2014-04-07Mr. Daniel ElgerExecutive Director,Chief Financial Officer
2015-10-29Dr. Rajesh ChopraNon-Executive Director
2023-05-01Mr. Ahmad Ali Mortazavi Executive Director,Chief Executive Officer
2022-05-04Mr. Steven MedlicottExecutive Director,Finance Director and Interim COO
2020-02-11Dr. Raymond John BarlowExecutive Director,Chief Executive Officer

E-Therapeutics PLC Contact Details

Company Namee-Therapeutics PLC
Address17 Blenheim Office Park, Long Hanborough, OX29 8LN
Telephone+44 1993880000
Websitehttps://www.etherapeutics.co.uk

E-Therapeutics PLC Advisors

AuditorDeloitte LLP
Phone+44 2079363000
Fax+44 2075831198
SolicitorStephenson Harwood
Phone+44 2073294422
Fax+44 2073297100
StockbrokerNumis Securities Limited
Phone+44 2072601000
Nominated AdviserNumis Securities Limited
Phone+44 2072601000
Fax+44 2072601001
AuditorDeloitte
Phone+44 2079363000
SolicitorBond Dickinson
Phone+44 3454150000
Fax+44 3454155256
Financial PR AdviserInstinctif Partners
Phone+44 2074572020
Fax+44 2078667900
RegistrarNeville Registrars Ltd
Phone+44 1215851131
Fax+44 1215851132
BankBank of Scotland
AuditorKPMG AUDIT PLC

Receive our
daily news email

Subscribe to the latest investing news by entering your email address below

You can opt out at any time.

For five days a week you will get

  • The latest company news
  • Insight into investment trends
  • Round-up of director's buys and sells
  • Articles from Shares magazine
Sharesmagazine cover

Plus more useful investment content and occasional promotional offers.

Shares Magazine Latest Issue Cover
Latest Issue:
18 Apr 2024Subscribe now

Market Overview

UK 350 Risers and Fallers

Risers

CompanyPrice% Chg
Pz Cussons PLC101.006.77
Darktrace PLC518.605.84
Rhi Magnesita N.V.3,630.004.76
Anglo American PLC2,205.004.45
Dunelm Group PLC1,008.003.97
Quilter PLC106.203.61

Fallers

CompanyPrice% Chg
Croda International PLC4,654.00-4.79
Breedon Group PLC364.50-4.08
Hammerson PLC26.72-3.95
Crest Nicholson Holdings PLC184.20-3.76
Ocado Group PLC364.60-3.49
Marshalls PLC256.50-3.39